All articles tagged with #manufacturing expansion
Micron Technology is emerging as a cornerstone of the AI boom by supplying DRAM and high-bandwidth memory (HBM) that power AI GPUs; with demand outstripping supply, Micron has booked its entire 2026 HBM output, and is expanding U.S. capacity with Virginia upgrades and new fabs in Idaho and New York, plus a $1.8B LOI to acquire a Taiwanese fabrication site, supported by a modest valuation around 5.5x forward sales and 11x forward earnings.
Joby Aviation plans to double its U.S. manufacturing capacity to produce four electric air taxis per month by 2027, supported by investments in facilities in California and Ohio, and a strategic alliance with Toyota, amid growing support for advanced air mobility and upcoming FAA certification milestones.
AstraZeneca plans to invest $50 billion in the US by 2030 to expand manufacturing and research, including a major new facility in Virginia, as part of its response to US trade tariffs and to bolster its US market presence, aiming for $80 billion in annual revenue by 2030.
Eli Lilly is investing an additional $5.3 billion to expand its manufacturing site in Indiana, aiming to increase production of its popular weight-loss and diabetes drugs, Zepbound and Mounjaro. The site, which began construction last year, is expected to start production by late 2026 and ramp up through 2028. This expansion marks the largest manufacturing investment in the company's history, driven by high demand for these treatments.